Evidence map›Paper›PMID 37508705›Full record

ArticleChildren (Basel, Switzerland)2023

Bloody Amniotic Fluid and Neonatal Outcomes.

Hanoch Schreiber, Gal Cohen, Hila Shalev-Ram, Sivan Farladansky-Gershnabel, Omer Weitzner, Tal Biron-Shental, Michal Kovo, Shmuel Arnon, Ofer Markovitch

Abstract read
In one paragraph

Article in Children (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hanoch SchreiberDepartment of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba 4428163, Israel.
Gal CohenDepartment of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba 4428163, Israel.
Hila Shalev-RamDepartment of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba 4428163, Israel.
Sivan Farladansky-GershnabelDepartment of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba 4428163, Israel.
Omer WeitznerDepartment of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba 4428163, Israel.
Tal Biron-ShentalDepartment of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba 4428163, Israel.
Michal KovoDepartment of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba 4428163, Israel.
Shmuel ArnonFaculty of Medicine, Tel Aviv University, Tel Aviv 6329302, Israel.ORCID 0000-0002-6765-1583
Ofer MarkovitchDepartment of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba 4428163, Israel.ORCID 0000-0002-1788-4143

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Information on the effect of bloody amniotic fluid during labor at term is scarce. This study assessed risk factors and adverse outcomes in labors with bloody amniotic fluid. During the six years of this study, all nulliparas in our institution, with a trial of labor, were included. Multiple pregnancies and preterm deliveries were excluded. Outcomes were compared between the bloody amniotic fluid group and the clear amniotic fluid group. Overall, 11,252 women were included. Among them, 364 (3.2%) had bloody amniotic fluid and 10,888 (96.7%) had clear amniotic fluid. Women in the bloody amniotic fluid group were characterized by shorter duration of the second stage and higher rate of cesarean section due to non-reassuring fetal heart rate. In addition, there were higher rates of low cord pH (<7.1) and NICU admissions in the bloody amniotic fluid group. In multivariate logistic regression analysis, cesarean delivery, cord blood pH < 7.1, and NICU admission were independently associated with increased odds ratio for bloody amniotic fluid. Bloody amniotic fluid at term is associated with adverse outcomes and must be considered during labor.

Indexed as

adverse maternal outcomesadverse neonatal outcomesbloody amniotic fluidplacental abruption

Identifiers

PMID37508705
PMCPMC10378302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.